Emergent BioSolutions (EBS) Announces 2 Countermeasures in its Anthrax Franchise Have Been Included in the PREP Act
Tweet Send to a Friend
Emergent BioSolutions Inc. (NYSE: EBS) announced today that two medical countermeasures included in its anthrax franchise -- BioThrax(R) (Anthrax Vaccine ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
